Role of the integrin αVβ3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress

Growth Hormone and IGF Research

Volumn 17, Issue 4, 2007, Pages 265-270

  Clemmons, David R ^a   Maile, Laura A ^a   Ling, Yan ^a   Yarber, J ^a   Busby, Walker H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cell migration; Diabetes; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN SHC; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; THROMBOSPONDIN; VITRONECTIN; VITRONECTIN RECEPTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL SIZE; ENZYME ACTIVATION; HUMAN; HYPERGLYCEMIA; MITOGENESIS; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE FIBER; STRESS;

ANIMALS; BLOOD GLUCOSE; HYPERGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; INTEGRIN ALPHAVBETA3; MODELS, BIOLOGICAL; MYOCYTES, SMOOTH MUSCLE; STRESS;

EID: 34547164352     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.01.004     Document Type: Review

References (41)

1. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
2. Miyamoto S., Teramoto H., Gutkind J.S., and Yamada K.M. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell. Biol. 135 (1996) 1633-1642
3. Senger Dr., Claffey K.P., Benes J.E., et al. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. USA 94 (1997) 13612-13617
4. Yayon A., Kglasburn M., Esko J.D., et al. Cell surface, heparin-like molecules are required for binding or basic fibroblast growth factor to its high affinity receptor. Cell 64 (1991) 841-848
5. Hemler M.E. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 6 (2005) 801-811
6. Vuori K., and Ruoslahti E. Association of insulin receptor substrate-1 with integrins. Science 266 (1994) 1576-1578
7. Schneller M., Vuori K., and Ruoslahte E. αVβ3 Integrin associates with activated insulin and PDGF β receptors and potentiates the biological activity of PDGF. EMBO J. 16 (1997) 5600-5607
8. Jones J.I., Gockerman A., Busby Jr. W.H., et al. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA 90 (1993) 10553-10557
9. Jones J.I., Gockerman A., Busby Jr. W.H., et al. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J. Cell Biol. 121 (1993) 679-687
10. Horton M.A. The alpha V beta 3 integrin "vitronectin receptor". Int. J. Biochem. Cell Biol. 29 (1997) 721-725
11. Samanna V., Wei H., Ego-Osuala D., and Chellajah M.A. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion and cell migration by osteopontin in human melanoma cells. Exp. Cell Res. 312 (2006) 2214-2230
12. Phillips D.R., Prasad K.S., Manganello J., et al. Integrin tyrosine phosphorylation in platelet signaling. Curr. Opin. Cell Biol. 13 (2001) 546-554
13. Jenkins A.L., Nannizzi-Alaimo L., Silver D., et al. Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions. J. Biol. Chem. 273 (1998) 13878-13885
14. Gaus K., Le Lay S., Balasubramanian N., and Schwartz M.A. Integrin-mediated adhesion regulates membrane order. J. Cell Biol. 174 (2006) 725-734
15. Cohen L.A., and Guan J.L. Mechanisms of focal adhesion kinase regulation. Curr. Cancer Drug Targets 5 (2005) 629-643
16. Frame M.C. Src in cancer: deregulation and consequences for cell behavior. Biochim. Biophys. Acta 1602 (2002) 114-130
17. Turner C.E. Paxillin interactions. J. Cell Sci. 23 (2000) 4139-4140
18. Duong L.T., and Rodan G.A. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation. Front. Biosci. 3 (1998) 757-768
19. Gockerman A., Prevette T., Jones J.I., and Clemmons D.R. Insulin-like growth factor (IGF) binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology 135 (1995) 4168-4173
20. Jones J.I., Doerr M.E., and Clemmons D.R. Cell migration: interactions among integrins. IGFs and IGFBPs. Prog. Growth Factor Res. 6 (1995) 319-327
21. Zheng B., and Clemmons D.R. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor-I signaling in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 95 (1998) 11217-11222
22. Ling Y., Maile L.A., Badley-Clarke J., and Clemmons D.R. DOK-1 mediates SHP-2 binding to the alphaVbeta3 integrin and thereby regulates insulin-like growth factor I signaling in cultured vascular smooth muscle cells. J. Biol. Chem. 280 (2005) 3151-3158
23. Maile L.A., and Clemmons D.R. Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2. J. Biol. Chem. 277 (2002) 8955-8960
24. Oshima K., Ruhul Amin A.R., Suzuki A., et al. SHPS-1, a multifunctional transmembrane glycoprotein. FEBS Lett. 519 (2002) 1-7
25. Ling Y., Maile L.A., and Clemmons D.R. Tyrosine phosphorylation of the beta3-subunit of the alphaVbeta3 integrin is required for membrane association of the tyrosine phosphatase SHP-2 and its further recruitment to the insulin-like growth factor I receptor. Mol. Endocrinol. 17 (2003) 1824-1833
26. Imai Y., and Clemmons D.R. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I. Endocrinology 140 (1999) 4228-4235
27. Ling Y., Maile L.A., Lieskovska J., et al. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells. Mol. Biol. Chem. 16 (2005) 3353-3364
28. Lieskovska J., Ling Y., Badley-Clarke J., and Clemmons D.R. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. J. Biol. Chem. 281 (2006) 25041-25053
29. Robertson L.A., Kim A.J., and Werstuck G.H. Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3. Can. J. Physiol. Pharmacol. 84 (2006) 39-48
30. Cercek B., Fishbein M.C., Forrester J.S., et al. Induction of insulin-like growth factor-I messenger RNA in rate aorta after balloon denudation. Circ. Res. 66 (1990) 1755-1760
31. Khorsandi M.J., Fagin J.A., Giannella-Neto D., et al. Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity. J. Clin. Invest. 90 (1992) 1926-1931
32. Zhu B., Zhao G., Witte D.P., et al. Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intraarterial injury. Endocrinology 142 (2001) 3598-3606
33. Zhang M., Smith E.P., Kuroda H., et al. Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy. J. Biol. Chem. 277 (2002) 21285-21290
34. Hayry P., Myllarniemi M., Aavik E., et al. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in rat. FASEB J. 9 (1995) 1336-1344
35. Campbell M., Allen W.E., Silversides J.A., and Trimble E.R. Glucose-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase-dependent upregulation of the platelet-derived growth factor-beta receptor potentiates vascular smooth muscle cell chemotaxis. Diabetes 52 (2003) 519-526
36. Holmes D.I.R., Wahab N.A., and Mason R.M. Identification of glucose-regulated genes in human mesangial cells by mRNA differential display. Biochem. Biophys. Res. Commun. 238 (1997) 179-184
37. Kawamura H., Yokote K., Asaumi S., et al. High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Aterioscler. Thromb. Vas. Biol. 24 (2004) 276-281
38. Stenina O.I., Krukovets I., Wang K., et al. Increased expression of thrombospondin-1 in vessel wall of diabetic zucker rat. Circulation 107 (2003) 3209-3215
39. Maile L.A., Busby W.H., Sitko K., et al. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of the alphaVbeta3. Mol. Endocrinol. 20 (2006) 405-413
40. Maile L.A., Busby W.H., Sitko K., et al. The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Mol. Endocrinol. 20 (2005) 881-892
41. L.A. Maile, B.E. Capps, Y. Ling, et al., Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Endocrinology, 2007 [Epub ahead of print].